Efficacy and safety of fixed-dose combination of Bilastine-Montelukast in adult patients with allergic rhinitis: a phase III, randomized, multi-center, double-blind, active controlled clinical study-Reference-Cited by-同舟云学术

Efficacy and safety of fixed-dose combination of Bilastine-Montelukast in adult patients with allergic rhinitis: a phase III, randomized, multi-center, double-blind, active controlled clinical study

Published:2023-05-31 Issue:11 Volume:60 Page:2014-2020
ISSN:0277-0903
Container-title:Journal of Asthma
language:en
Short-container-title:Journal of Asthma

Author:

Sinha Shubhadeep D.¹^ORCID,Perapogu Sridevi²,Chary S. Sreenivasa¹^ORCID,Ramesh S.³,Bakshi Jaimanti⁴,Singh Ajit⁵,Ahmed Abdul Khabeer⁶,Mohan Reddy B.¹,Panapakam Muralidhar¹,Talluri Leela¹^ORCID,Vattipalli Ramya¹

Affiliation:

1. Department of Clinical Development & Medical Affairs, Hetero, Hyderabad, Telengana, India

2. Department of ENT, Government Medical College & Hospital, SPSR, Nellore, Andhra Pradesh, India

3. Department of ENT, Govt Medical College & Govt General Hospital, Srikakulam, Andhra Pradesh, India

4. Department of ENT, Postgraduate Institute of Medical Education and Research, Chandigarh, India

5. Division of Allergy & Pulmonary Medicine, Dhanvantri OPD Block, SMS Hospital, Jaipur, Rajasthan, India

6. Department of ENT, Gandhi Hospital, Secunderabad, Telangana, India

Publisher

Informa UK Limited

Subject

Pulmonary and Respiratory Medicine,Immunology and Allergy,Pediatrics, Perinatology and Child Health

Link

https://www.tandfonline.com/doi/pdf/10.1080/02770903.2023.2209175

Reference19 articles.

1. Allergic rhinitis: Definition, epidemiology, pathophysiology, detection, and diagnosis

2. A practical approach to allergic rhinitis and sleep disturbance management

3. Economic impact of workplace productivity losses due to allergic rhinitis compared with select medical conditions in the United States from an employer perspective

4. World Allergy Organization (WAO) White Book on Allergy: 2013. Available from: https://www.worldallergy.org/UserFiles/file/WhiteBook2-2013-v8.pdf [last accessed 9 December 2022].

5. Preclinical Pharmacology of Bilastine,??a New Selective Histamine??H1 ??Receptor Antagonist